Business services, nec, nec
Transcripta Bio, Inc
Transcripta Bio, Inc., based in Palo Alto, California, is at the forefront of transcriptome-driven drug discovery, utilizing artificial intelligence to generate comprehensive transcriptomic data that reveals how various drugs influence gene activity. Their platform enables the mapping of chemical structures to gene expression across a vast number of genes, facilitating improved treatment decision-making.
The company has developed a high-resolution transcriptomic perturbation atlas that integrates small molecules and diverse cell atlases to identify therapeutic opportunities for a wide range of human diseases. By rapidly synthesizing and validating novel compounds in their lab, Transcripta Bio transforms insights into innovative therapies, positioning themselves as a leader in maximizing therapeutic hypotheses through advanced analytics. Generated from the website